BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 3593184)

  • 1. Effects of lidoflazine and mioflazine against potassium and veratrine induced shape changes in isolated rat cardiac myocytes.
    Ver Donck L; Liu GS; Vandeplassche G; Borgers M
    Basic Res Cardiol; 1987; 82(1):74-81. PubMed ID: 3593184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolated rat cardiac myocytes as an experimental model to study calcium overload: the effect of calcium-entry blockers.
    Donck LV; Pauwels PJ; Vandeplassche G; Borgers M
    Life Sci; 1986 Mar; 38(9):765-72. PubMed ID: 3951332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protection of human, rat, and guinea-pig atrial muscle by mioflazine, lidoflazine, and verapamil against the destructive effects of high concentrations of Ca2+.
    Ravens U; Liu GS; Vandeplassche G; Borgers M
    Cardiovasc Drugs Ther; 1992 Feb; 6(1):47-58. PubMed ID: 1576096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of stimulation and veratrine on total cellular calcium in rat and guinea-pig ventricular myocytes.
    Henden T; Larsen TS; Lathrop DA
    Basic Res Cardiol; 1993; 88(6):557-65. PubMed ID: 8147821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential inhibition of nucleoside transport systems in mammalian cells by a new series of compounds related to lidoflazine and mioflazine.
    Griffith DA; Conant AR; Jarvis SM
    Biochem Pharmacol; 1990 Nov; 40(10):2297-303. PubMed ID: 2244931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathophysiology of cardiomyocytes.
    Borgers M; Ver Donck L; Vandeplassche G
    Ann N Y Acad Sci; 1988; 522():433-53. PubMed ID: 3288055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of calcium antagonists on calcium overload contractures in embryonic chick myocytes induced by ouabain and veratrine.
    Patmore L; Duncan GP; Spedding M
    Br J Pharmacol; 1989 May; 97(1):83-94. PubMed ID: 2470461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mioflazine, a potentially protective drug against ischaemic damage: a study in dogs.
    Wood AJ; Isted K; Hynd J; Main MJ; Noble MI; Parker J; Drake-Holland AJ
    Eur Heart J; 1985 Aug; 6(8):695-701. PubMed ID: 4054139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nucleoside influx and efflux in guinea-pig ventricular myocytes. Inhibition by analogues of lidoflazine.
    Conant AR; Jarvis SM
    Biochem Pharmacol; 1994 Aug; 48(5):873-80. PubMed ID: 8093099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of nucleoside transport by a new series of compounds related to lidoflazine and mioflazine.
    Ijzerman AP; Thedinga KH; Custers AF; Hoos B; Van Belle H
    Eur J Pharmacol; 1989 Aug; 172(3):273-81. PubMed ID: 2776845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Protective effects of lidoflazine and mioflazine in ischemic myocardium].
    Liu GS; Borgers M; Xhonneux R
    Zhonghua Xin Xue Guan Bing Za Zhi; 1988 Apr; 16(2):100-2, 127. PubMed ID: 3197595
    [No Abstract]   [Full Text] [Related]  

  • 12. Inhibition of nucleoside uptake in human erythrocytes by a new series of compounds related to lidoflazine and mioflazine.
    Pirovano IM; Van Belle H; Ijzerman AP
    Eur J Pharmacol; 1990 Dec; 189(6):419-22. PubMed ID: 2073930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebral ischemia and reperfusion: prevention of brain mitochondrial injury by lidoflazine.
    Rosenthal RE; Hamud F; Fiskum G; Varghese PJ; Sharpe S
    J Cereb Blood Flow Metab; 1987 Dec; 7(6):752-8. PubMed ID: 3693430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myocardial protective effects of lidoflazine during ischemia and reperfusion.
    Guvendik L; Hynd J; Drake-Holland A; Parker DJ
    Thorac Cardiovasc Surg; 1990 Feb; 38(1):15-9. PubMed ID: 2309223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitory effect of lidoflazine on contractions of isolated canine coronary arteries caused by norepinephrine, 5-hydroxytryptamine, high potassium, anoxia and ergonovine maleate.
    Van Neuten JM; Van Beek J; Vanhoutte PM
    J Pharmacol Exp Ther; 1980 Apr; 213(1):179-87. PubMed ID: 7359366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relaxing effects of dilazep and lidoflazine in dog cerebral and renal arteries independent of adenosine.
    Mustafa SJ; Nakagawa Y
    Pharmacology; 1988; 37(2):75-84. PubMed ID: 3212039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective effect of bepridil against veratrine-induced contracture in rat atria.
    Leboeuf J; Baissat J; Massingham R
    Eur J Pharmacol; 1992 Jun; 216(2):183-9. PubMed ID: 1397005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pretreatment with lidoflazine, a calcium-channel blocker. Useful adjunct to heterogeneous cold potassium cardioplegia.
    Kates RA; Dorsey LM; Kaplan JA; Hatcher CR; Guyton RA
    J Thorac Cardiovasc Surg; 1983 Feb; 85(2):278-86. PubMed ID: 6823146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tissue specificity of calcium-antagonistic properties of lidoflazine.
    Van Nueten JM; Wellens D
    Arch Int Pharmacodyn Ther; 1979 Dec; 242(2):329-31. PubMed ID: 543767
    [No Abstract]   [Full Text] [Related]  

  • 20. Does if control normal automatic rate in canine cardiac Purkinje fibers? Studies on the negative chronotropic effects of lidoflazine.
    Dangman KH; Miura DS
    J Cardiovasc Pharmacol; 1987 Sep; 10(3):332-40. PubMed ID: 2444783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.